NASDAQ · Biotechnology

ImageneBio, Inc. (IMA) Stock

$4.00 -0.99% NASDAQ: IMA Healthcare

Valuation

Metric	Value
Price	$4.00
Market Cap	$45.41M
P/E Ratio	-0.87
P/B Ratio	0.52
P/S Ratio	53.80
EPS (TTM)	$-3.37
52-Week High	$9.10
52-Week Low	$3.94
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-38.99%
ROA	-34.52%
ROCE	-40.53%
Gross Margin	—
Operating Margin	-4800.00%
Net Margin	-4500.00%
Debt/Equity	0.01
Current Ratio	12.73

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$31.0M	$16.0M	$9.0M	$4.0M	$1.0M
Operating Profit	$-34.0M	$-71.0M	$-75.0M	$-37.0M	$-48.0M
Net Profit	$-34.0M	$-69.0M	$-68.0M	$-37.0M	$-45.0M
EPS	$-11.38	$-22.80	$-19.60	$-40.52	$-9.64
Op Margin	-110.2%	-454.0%	-823.3%	-1057.1%	-6056.4%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$248.0M	$172.0M	$192.0M	$142.0M	$153.0M
Total Liabilities	$40.0M	$25.0M	$22.0M	$16.0M	$20.0M
Cash	$232.0M	$60.0M	$120.0M	$39.0M	$35.0M
Borrowings	$7.0M	$6.0M	$11.0M	$8.0M	$10.0M

Latest News

ImageneBio Appoints Matt Robbins as General Counsel GlobeNewswire · Jul 7, 2026 ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York GlobeNewswire · May 27, 2026 ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update GlobeNewswire · May 7, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-60.0M	$-74.0M	$-80.0M	$-46.0M	$-48.0M
Investing Cash Flow	$-4.0M	$-101.0M	$64.0M	$-35.0M	$-6.0M
Financing Cash Flow	$1.0M	$1.0M	$38.0M	$0	$55.0M
Net Cash Flow	$70.0M	$-172.0M	$60.0M	$-81.0M	$82.0M
Free Cash Flow	$-62.0M	$-76.0M	$-80.0M	$-46.0M	$-48.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.01
EV / EBITDA	0.78
FCF Yield	-112.50%
Quick Ratio	21.47
Interest Coverage	-614.18
Return 1Y	-63.38%
Return 3Y	-91.79%
Return 5Y	-95.68%

Ownership

Insiders Held11.26%

Institutions Held48.16%

Institutions Float Held54.27%

Institutional Holder	Shares	Report Date
BVF Inc.	1,110,002	2026-03-31
Blue Owl Capital Holdings LP	959,337	2026-03-31
Orbimed Advisors LLC.	909,269	2026-03-31
Cable Car Capital, LP	754,749	2026-03-31
Omega Fund Management, Llc	455,361	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAPLApple Inc.	$342.94	-0.15%	38.93	$5.00T	0.32%
MSFTMicrosoft Corporation	$533.52	+0.84%	28.68	$3.96T	0.76%
GOOGLAlphabet Inc.	$344.18	+1.05%	16.94	$4.19T	0.26%
AMZNAmazon.com, Inc.	$262.45	+4.98%	19.82	$2.83T	0.00%
METAMeta Platforms, Inc.	$705.44	-0.55%	27.93	$1.80T	0.28%

About ImageneBio, Inc.

ImageneBio, Inc. is led by CEO Kristin Yarema, employs 10 people, headquartered in US, publicly traded since 1998.

ImageneBio, Inc. (IMA) stock trades at $4.00 with a market capitalization of $45.41M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.87, reflecting a net loss over the last twelve months, price-to-book of 0.52, price-to-sales of 53.80. Over the past 52 weeks the stock has ranged between $3.94 and $9.10, and currently trades 56.0% below its 52-week high.

On profitability, ImageneBio, Inc. generates a return on equity (ROE) of -38.99% (negative, reflecting a net loss), return on capital employed of -40.53%, an operating margin of -4800.00%, a net profit margin of -4500.00%.

ImageneBio, Inc. (IMA) — frequently asked questions

What is ImageneBio, Inc. (IMA) stock price today?

ImageneBio, Inc. (IMA) is currently trading at $4.00, down 0.99% today.

What is IMA P/E ratio?

ImageneBio, Inc.'s P/E ratio is -0.87. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is IMA return on equity (ROE)?

ImageneBio, Inc.'s return on equity (ROE) is -38.99%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is ImageneBio, Inc.'s market cap?

ImageneBio, Inc. has a market capitalization of $45.41M.

Related Healthcare Stocks

LLY Eli Lilly and Company $1240.34 -1.33% JNJ Johnson & Johnson $253.79 -0.69% ABBV AbbVie Inc. $282.78 -0.92% UNH UnitedHealth Group Incorporated Common Stock (DE) $406.88 +1.36% MRK Merck & Company, Inc. Common Stock (new) $143.67 -1.56% NVS Novartis AG $150.20 -0.28% AZN AstraZeneca PLC $163.95 -0.88% TMO Thermo Fisher Scientific Inc $679.38 -1.54% AMGN Amgen Inc. $424.94 -1.75% GILD Gilead Sciences, Inc. $153.07 -2.00% ABT Abbott Laboratories $104.06 -0.79% NVO Novo Nordisk A/S $38.42 -1.06%

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.